Welcome to Affomix

Affomix has proprietary technology for rapid, automated, high-throughput selection of human monoclonal antibodies (mAbs).  Our mission is to commercialize proprietary mAbs, mAb microarrays and mAb libraries for research, drug discovery, diagnostic and therapeutic applications, with a particular focus on the use of our mAbs for sensitive and accurate measurement of very large numbers of proteins in biological samples. 

Affomix technology is designed to select mAbs that possess high levels of affinity and specificity toward their antigens.  Because of its high-throughput capabilities, Affomix is able to provide customers with sets of mAbs at unrivalled speeds and prices.

Affomix has the ultimate objective of mining its extensive human mAb libraries to generate the human Affome^TM, a comprehensive library of mAbs that can be used to detect and quantify all proteins in the human proteome.  Affomix is perfecting a proprietary protein quantitation technology to enable the development of highly multiplexed proteome arrays.